P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases. In November 2025, P95 merged with Julius Clinical, to provide additional expertise neuroscience and cardio-renal-metabolic research. Together, we offer full-service CRO solutions across 5 continents, with a team of 500 professionals, and over 25 years of collective experience. We continue to be dedicated to delivering flexible, customer-centrical solutions, powered by a team that is passionate about driving positive change in global health. We offer a range of high-quality services including: - Clinical Trials Phase I-IV - Epidemiology and RWE - Vaccine Development Consulting - Study Start-up and Regulatory - Clinical Monitoring - Home Nursing - Sample Management - Medical Monitoring - Pharmacovigilance - Data Management - Biostatistics - Medical Writing - Qualitative Research
Looking for a particular P95 employee's phone or email?
P95 Questions
The P95 annual revenue was $3 million in 2026.
Stefaan Castelein is the CFO of P95.
163 people are employed at P95.
P95 is based in Heverlee, Flanders.
The NAICS codes for P95 are [541, 54169, 54, 5416].
The SIC codes for P95 are [87, 874].
Top P95 Employees
-
Stefaan Castelein
CFO at P95
Antwerp, BE22 -
Catherine Lund
CEO P95 Africa at P95
Johannesburg, GP, ZA13 -
John O'Brien
Chief Business Officer at P95
Île-de-France, France23 -
Laurence de Moerlooze
Chief Medical Officer at P95
Zürich, ZH, CH22 -
1
-
Anne Hepburn
Senior Advisor at P95
Brussels, BE24 -
1
-
Owain Lewis
Business Development Director at P95
Bordeaux, FR1
Related Companies
